Company Monitoring Page for Novartis

latest headlines for company on cafepharma

The Top 5 Drug Patents Expiring in 2017
Investopedia
Mon, 01/16/17 - 11:48 am
Tags:
patents, Novartis, Eli Lilly, Merck, Bristol-Myers Squibb, Sandostatin LAR, Cubicin, Reyataz, Vytorin, Strattera
How Did Novartis Perform in 3Q16?
Market Realist
Mon, 01/16/17 - 10:31 am
Tags:
Novartis
Amgen Fight Over Copies of Biotech Drugs Gets High Court Review
Bloomberg
Sat, 01/14/17 - 03:35 pm
Tags:
Amgen, Supreme Court, Neupogen, Novartis, Sandoz, biosimilars
Why Novartis Dropped 15.1% in 2016
Motley Fool
Wed, 01/11/17 - 10:00 am
Tags:
Novartis, Gleevec, Diovan, patents, generics
3 Takeover Candidates in the Drug Space
TheStreet.com
Mon, 01/9/17 - 09:45 am
Tags:
M&A, Gilead Sciences, JNJ, Pfizer, Merck, Novartis, Eli Lilly, Bristol-Myers Squibb, Biogen
Greek prosecutors raid Novartis offices, disclose wide-ranging probe into bribery allegations
Fierce Pharma
Wed, 01/4/17 - 10:45 am
Tags:
Greece, Novartis, bribery
Novartis, Sun Pharma enter deal for oncology drug Odomzo
BioPharma Dive
Sat, 12/24/16 - 12:23 pm
Tags:
Novartis, Sun Pharma, oncology, Odomzo, skin cancer
The Most Likely Incyte Acquisition Deal for 2017?
Motley Fool
Sat, 12/24/16 - 12:11 pm
Tags:
M&A, Incyte, Gilead Sciences, Lilly, Novartis, Agenus
Novartis sells US rights to three COPD drugs
BioPharma Dive
Thu, 12/22/16 - 10:05 am
Tags:
Novartis, COPD, Sunovion
Novartis bags a new eczema drug, builds dermatology pipeline with Ziarco buyout
Endpoints
Fri, 12/16/16 - 11:34 am
Tags:
Novartis, eczema, dermatology, M&A, ZPL389, Ziarco
Novartis' Big News at ASH? It's Still in the CAR-T Race
Motley Fool
Fri, 12/16/16 - 11:28 am
Tags:
Novartis, ASH, CAR-T, CTL-019
Don't Buy The Depomed Buyout Rumors; Buy The Certainty Of An Eventual Deal
Seeking Alpha
Thu, 12/8/16 - 11:13 pm
Tags:
Depomed, Novartis, M&A
Has GlaxoSmithKline Finally Turned the Corner?
Motley Fool
Tue, 12/6/16 - 09:43 am
Tags:
GSK, Novartis, Breo Ellipta, Anoro Ellipta
Novartis Makes Its Case For Driving A CAR Into The Real World
Seeking Alpha
Mon, 12/5/16 - 10:43 pm
Tags:
Novartis, CAR-T, Kite Pharma, CTL019, KTE-C19
Are DTC ads tipping the balance in psoriasis battle between Lilly’s Taltz and Novartis’ Cosentyx?
Fierce Pharma
Mon, 12/5/16 - 10:10 am
Tags:
DTC advertising, psoriasis, Eli Lilly, Novartis, Taltz, Cosentyx
What makes a PhII drug worth up to $665M? Researchers spell it out for Novartis
Endpoints
Mon, 12/5/16 - 09:48 am
Tags:
Novartis, crizanlizumab, sickle cell disease, M&A, Selexys
Novartis CEO plays down prospects for Actelion bid
Yahoo/Reuters
Sun, 12/4/16 - 12:33 pm
Tags:
Novartis, Actelion, M&A, Pharma CEOs, Joe Jimenez
In wake of a CAR-T restructuring, Novartis says it’s ready to hunt a pioneering OK for lead program
Endpoints
Sun, 12/4/16 - 12:24 pm
Tags:
Novartis, CAR-T, CTL019, B-cell acute lymphoblastic leukemia
Novartis donates $10M in generics to global relief
BioPharma Dive
Mon, 11/28/16 - 11:29 pm
Tags:
Novartis, generics, philanthropy, Sandoz
Novartis Social Media Network for Patients - Is This a Good Idea
CP Wire
Mon, 11/28/16 - 01:13 pm
Tags:
Novartis, social media, heart failure

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.